Upload

Loading...

  1. 164

    Periodic fever syndromes

  2. 165

    Journey of Chronic Myeloid Leukemia: A collaborative effort between the EHA and Novartis

  3. 166

    A lifelong challenge: periodic fever syndromes

  4. 167

    Connections

  5. 168

    Each Voice Counts - The Women: Part 1

  6. 169

    Each Voice Counts - The Women: Part 2

  7. 170

    Unanswered questions about living with advanced breast cancer

  8. 171

    Count Us, Know Us, Join Us - The Path of Advanced Breast Cancer

  9. 172

    Novartis International Biotechnology Leadership Camp 2012

  10. 173

    Journey of Chronic Myeloid Leukemia (CML)

  11. 174

    A look at the past decade in GIST: Chapter 6

  12. 175

    A look at the past decade in GIST: Chapter 5

  13. 176

    A look at the past decade in GIST: Chapter 4

  14. 177

    Vision loss due to Retinal Vein Occlusion (RVO)

  15. 178

    Vision loss due to Diabetic Macular Edema (DME)

  16. 179

    Vision loss due to wet age-related macular degeneration (wet AMD)

  17. 180

    A look at the past decade in GIST: Chapter 3

  18. 181

    Building the next generation of scientists

  19. 182

    A look at the past decade in GIST: Chapter 2

  20. 183

    A look at the past decade in GIST: Chapter 1

  21. 184

    The impact of systemic juvenile idiopathic arthritis (SJIA)

  22. 185

    A difficult diagnosis: Understanding systemic juvenile idiopathic arthritis (SJIA)

  23. 186

    Advanced breast cancer 101

  24. 187

    The mTOR pathway in ER+ advanced breast cancer

  25. 188

    Life in a Circle

  26. 189

    Understanding advanced breast cancer

  27. 190

    A Gift for Living

  28. 191

    The Villages Miles Away

  29. 192

    Be Healthy: the first company-wide health and well-being initiative at Novartis

  30. 193

    Innovating to help eliminate malaria

  31. 194

    Malaria milestone video message

  32. 195

    Leo and Kya, friends against malaria

  33. 196

    The need for progress: what if?

  34. 197

    The myelofibrosis educational journey

  35. 198

    Understanding the progression of myelofibrosis

  36. 199

    Understanding the management of myelofibrosis

  37. 200

    The myelofibrosis disease burden

  38. 201

    The disease pathway associated with myelofibrosis

  39. 202

    New research developments in myelofibrosis

  40. 203

    Delivery of child-friendly antimalarial hits the 100 million mark

  41. 204

    Treating India's Leprosy patients

  42. 205

    Treating leprosy, caring for patients

  43. 206

    "SMS for Life" is expanding

  44. 207

    Becoming Christopher a fictional video trailer about living with Cystic Fibrosis

  45. 208

    Critical issues facing the advanced breast cancer patient community

  46. 209

    Advice to newly diagnosed advanced breast cancer patients

  47. 210

    Insight into the advanced breast cancer patient journey

  48. 211

    Pioneering an innovative social business model to fight malaria

  49. 212

    New media: drivers of democratization and development?

  50. 213

    What is it like living with myelofibrosis (MF)?

  51. 214

    What is the prognosis of myelofibrosis (MF)?

  52. 215

    How are myeloproliferative neoplasms (MPNs) diagnosed?

  53. 216

    What do we know about the development of myeloproliferative neoplasms (MPNs)?

  54. 217

    What is myelofibrosis (MF)?

  55. 218

    How is the patient journey for advanced breast cancer patients different?

  56. 219

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  57. 220

    What is progression free survival and why is it important?

  58. 221

    What guidance do you give patients and family coping with advanced breast cancer?

  59. 222

    What insights can you share with newly diagnosed patients?

  60. 223

    Molecular pathways:The future of research at NIBR

  61. 224

    The importance of organ donation

  62. 225

    Novartis BioCamp 2011 (German)

  63. 226

    Novartis BioCamp 2011 (French)

  64. 227

    How is research in advanced breast cancer evolving?

  65. 228

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  66. 229

    What can a patient expect if diagnosed with advanced breast cancer?

  67. 230

    What is progression free survival (PFS) as it relates to metastatic breast cancer therapy?

  68. 231

    What is the evolution of treatments and the progress that has been made in metastatic breast cancer?

  69. 232

    How does the advanced breast cancer treatment journey differ for patients?

  70. 233

    Novartis Be Healthy

  71. 234

    Novartis BioCamp 2011

  72. 235

    A sign from above

  73. 236

    Charlie

  74. 237

    Happy endings

  75. 238

    Herpes #1

  76. 239

    Herpes it's black and white

  77. 240

    Herpes the Ninja virus

  78. 241

    Magical elves with HSV

  79. 242

    Open happiness

  80. 243

    Play it smart

  81. 244

    Quarantine

  82. 245

    Strings

  83. 246

    Ah! Real herpes

  84. 247

    Down there

  85. 248

    Don't let herpes put you off

  86. 249

    Arogya Parivar: A social business model to improve health in rural India

  87. 250

    Living with multiple myeloma

  88. 251

    What are the symptoms of myelofibrosis (MF)?

  89. 252

    Gastrointestinal Stromal Tumors (GIST): A rare, life-threatening cancer

  90. 253

    Animals & Research: Think how far we've come

  91. 254

    SMS for Life

  92. 255

    Alcon: helping the world see better

  93. 256

    Cataract Surgery

  94. 257

    Life with cataracts

  95. 258

    CEO Joseph Jimenez on Alcon merger

  96. 259

    Improving access to healthcare: too big to solve alone

  97. 260

    Drug discovery and development process

  98. 261

    How bacterial meningitis affects the body

  99. 262

    10 years of Millennium Development Goals

Sign in to add this to Watch Later

Add to